Target Corp. (NYSE: TGT) Q3 2020 earnings call dated Nov. 18, 2020
Corporate Participants:
John Hulbert — Vice President, Investor Relations
Brian Cornell — Board Chairman and Chief Executive Officer
John J. Mulligan — Executive Vice President and Chief Operating Officer
Michael Fiddelke — Executive Vice President and Chief Financial Officer
Analysts:
Chris Horvers — J.P. Morgan — Analyst
Stephanie Wissink — Jefferies — Analyst
Edward Kelly — Wells Fargo Securities, LLC — Analyst
Edward Yruma — KeyBanc Capital Markets Inc. — Analyst
Karen Short — Barclays — Analyst
Paul Lejuez — Citigroup — Analyst
Paul Trussell — Deutsche Bank AG — Analyst
Robert Ohmes — Bank of America Merrill Lynch — Analyst
_____
To read the full earnings call transcript, click here.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on